Escalon Medical Corp Performance
| ESMCDelisted Stock | USD 0.06 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.87, which means possible diversification benefits within a given portfolio. Escalon Medical returns are very sensitive to returns on the market. As the market goes up or down, Escalon Medical is expected to follow. Escalon Medical Corp right now shows a risk of 0.0%. Please confirm Escalon Medical Corp standard deviation, potential upside, relative strength index, as well as the relationship between the jensen alpha and rate of daily change , to decide if Escalon Medical Corp will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Escalon Medical Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Escalon Medical is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
| Begin Period Cash Flow | 1.9 M | |
| Free Cash Flow | -1 M |
Escalon |
Escalon Medical Relative Risk vs. Return Landscape
If you would invest 6.00 in Escalon Medical Corp on August 31, 2024 and sell it today you would earn a total of 0.00 from holding Escalon Medical Corp or generate 0.0% return on investment over 90 days. Escalon Medical Corp is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Escalon, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Escalon Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Escalon Medical's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Escalon Medical Corp, and traders can use it to determine the average amount a Escalon Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ESMC |
Based on monthly moving average Escalon Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Escalon Medical by adding Escalon Medical to a well-diversified portfolio.
Escalon Medical Fundamentals Growth
Escalon OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Escalon Medical, and Escalon Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Escalon OTC Stock performance.
| Return On Equity | -0.42 | ||||
| Return On Asset | -0.0724 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | (0.06) % | ||||
| Current Valuation | 2.07 M | ||||
| Shares Outstanding | 7.42 M | ||||
| Price To Earning | 4.50 X | ||||
| Price To Book | 1.12 X | ||||
| Price To Sales | 0.05 X | ||||
| Revenue | 10.7 M | ||||
| EBITDA | 84.92 K | ||||
| Cash And Equivalents | 593.87 K | ||||
| Cash Per Share | 0.08 X | ||||
| Total Debt | 153.43 K | ||||
| Debt To Equity | 0.81 % | ||||
| Book Value Per Share | 0.07 X | ||||
| Cash Flow From Operations | (1.05 M) | ||||
| Earnings Per Share | 0.02 X | ||||
| Total Asset | 5.17 M | ||||
| Retained Earnings | (66.22 M) | ||||
| Current Asset | 4.13 M | ||||
| Current Liabilities | 2.78 M | ||||
About Escalon Medical Performance
By analyzing Escalon Medical's fundamental ratios, stakeholders can gain valuable insights into Escalon Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Escalon Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Escalon Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. Escalon Medical Corp. was incorporated in 1987 and is based in Wayne, Pennsylvania. Escalon Med operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 41 people.Things to note about Escalon Medical Corp performance evaluation
Checking the ongoing alerts about Escalon Medical for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Escalon Medical Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Escalon Medical Corp is not yet fully synchronised with the market data | |
| Escalon Medical Corp has some characteristics of a very speculative penny stock | |
| Escalon Medical Corp has a very high chance of going through financial distress in the upcoming years | |
| Escalon Medical Corp currently holds about 593.87 K in cash with (1.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.08, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Escalon Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Escalon Medical's stock is overvalued or undervalued compared to its peers.
- Examining Escalon Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Escalon Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Escalon Medical's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Escalon Medical's otc stock. These opinions can provide insight into Escalon Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Escalon OTC Stock
If you are still planning to invest in Escalon Medical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Escalon Medical's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |